Freakonomics Radio
It regulates 20 percent of the U.S. economy, and its commissioner has an aggressive agenda — faster drug approvals, healthier food, cures for diabetes and cancer. How much can he deliver? (Part two of “The Freakonomics Radio Guide to Getting Better.”)
- SOURCES:
- Marty Makary, commissioner of the Food and Drug Administration.
- RESOURCES:
- “Clinical Trials Affected by Research Grant Terminations at the National Institutes of Health,” by Vishal Patel, Michael Liu, and Anupam Jena (JAMA Internal Medicine, 2025).
- “What the evidence tells us about Tylenol, leucovorin, and autism,” by Matthew Herper (STAT, 2025).
- “I Run the F.D.A. Pharma Ads Are Hurting Americans.” by Marty Makary (New York Times, 2025).
- Blind Spots: When Medicine Gets It Wrong, and What It Means for Our Health, by Marty Makary (2024).
- EXTRAS:
- “Are You Really Allergic to Penicillin?” by Freakonomics Radio (2025).
- “How to Fix the Hot Mess of U.S. Healthcare,” by Freakonomics Radio (2021).
- “Bad Medicine, Part 3: Death by Diagnosis,” by Freakonomics Radio (2016).
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
431. Why Can’t Schools Get What the N.F.L. Has?
Thanks to daily Covid testing and regimented protocols, the new football season is underway. Meanwhile, most teachers, students, and parents are essentially waiting for the storm to pass. And school isn’t even a contact sport…
“I Started Crying When I Realized How Beautiful the Universe Is” | People I (Mostly) Admire Ep. 2: Mayim Bialik
She’s best known for playing neurobiologist Amy Farrah Fowler on The Big Bang Theory, but the award-winning actress has a rich life outside of her acting career, as a teacher, mother — and a real-life…
America’s Hidden Duopoly (Ep. 356 Rebroadcast)
We all know our political system is “broken” — but what if that’s not true? Some say the Republicans and Democrats constitute a wildly successful industry that has colluded to kill off competition, stifle reform,…
430. Will a Covid-19 Vaccine Change the Future of Medical Research?
We explore the science, scalability, and (of course) economics surrounding the global vaccine race. Guests include the chief medical officer of the first U.S. firm to go to Phase 3 trials with a vaccine candidate;…
Introducing “People I (Mostly) Admire”
A new interview show with host Steve Levitt. Today he speaks with the Harvard psychologist and linguist Steven Pinker. By cataloging the steady march of human progress, the self-declared “polite Canadian” has managed to enrage…
The Economics of Sports Gambling (Ep. 388 Rebroadcast)
What happens when tens of millions of fantasy-sports players are suddenly able to bet real money on real games? We’re about to find out. A recent Supreme Court decision has cleared the way to bring…
429. Is Economic Growth the Wrong Goal?
The endless pursuit of G.D.P., argues the economist Kate Raworth, shortchanges too many people and also trashes the planet. Economic theory, she says, “needs to be rewritten” — and Raworth has tried, in a book…
How the Supermarket Helped America Win the Cold War (Ep. 386 Rebroadcast)
Aisle upon aisle of fresh produce, cheap meat, and sugary cereal — a delicious embodiment of free-market capitalism, right? Not quite. The supermarket was in fact the endpoint of the U.S. government’s battle for agricultural…
428. The Simple Economics of Saving the Amazon Rain Forest
Everyone agrees that massive deforestation is an environmental disaster. But most of the standard solutions — scolding the Brazilians, invoking universal morality — ignore the one solution that might actually work
427. The Pros and Cons of Reparations
Most Americans agree that racial discrimination has been, and remains, a big problem. But that is where the agreement ends.